Tonix Pharmaceuticals Outlines Phase II Trial for TNX-4800 and TONMYA Expansion

Tonix Pharmaceuticals has detailed its Phase II clinical trial for TNX-4800, which will involve approximately 3,300 participants, while also planning to scale its TONMYA sales force to about 150 representatives by September.